Growth hormone (GH) is secreted by the pituitary in a pulsatile pattern that acts on tissues throughout the body both directly and through the stimulation of insulin-like growth factor 1 (IGF-1). Treatments that increase GH have been shown to be effective in the treatment of GH deficient children and adults, and also have wide ranging potential applications toward the relative GH deficiency associated with aging and obesity, the weight loss and muscle wasting of AIDS, and the agricultural production of milk and lean meat. Growth hormone-releasing hormone (GHRH) is a hypothalamic neuropeptide that acts as the major stimulus for GH synthesis and release. GHRH mediates its actions by binding to pituitary GHRH receptors (GHRH-R) and activating an intracellular signal transduction pathway. An improved understanding of GHRH receptor structure, function, physiology and regulation will reveal the information needed to facilitate clinical and pharmacological manipulations of the GH axis. Toward this goal we propose the following specific aims: 1. Which domains of the GHRH-R are in close proximity to bound GHRH? A panel of five GHRH photoaffinity crosslinking probes and three receptor-directed antisera will be used to identify receptor domains in close contact with specific residues of bound hormone. These results will then be used to establish structure/function relationships and suggest structural requirements for receptor activation. 2. What mechanisms are involved in GHRH-R down regulation? We will examine how the GHRH induced receptor modification we report here relates to receptor down regulation and internalization in stable cell lines, primary cultured rat pituitary, and in naturally truncated ovine receptor. The roles of PKC, PKA and betaARK kinases will be tested. Mutant receptors will be prepared to identify the receptor domains involved. 3. Is GHRH the primary regulator of GHRH-R and is GHRH-R expression directly correlates to hypothalamic GHRH drive? A rat model with GH suppression of hypothalamic drive to the somototroph will be examined. This suppression will be challenged by either elevating endogenous GHRH with intracerebroventricular injection of GH antagonist or by iv infusion of exogenous GHRH.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK045350-05A1
Application #
2468036
Study Section
Endocrinology Study Section (END)
Program Officer
Sato, Sheryl M
Project Start
1998-05-15
Project End
2001-11-30
Budget Start
1998-05-15
Budget End
1998-11-30
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Virginia
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Harvey, S; Gineste, C; Gaylinn, B D (2014) Growth hormone (GH)-releasing activity of chicken GH-releasing hormone (GHRH) in chickens. Gen Comp Endocrinol 204:261-6
Toogood, Andrew A; Harvey, Stephen; Thorner, Michael O et al. (2006) Cloning of the chicken pituitary receptor for growth hormone-releasing hormone. Endocrinology 147:1838-46
Horikawa, R; Gaylinn, B D; Lyons Jr, C E et al. (2001) Molecular cloning of ovine and bovine growth hormone-releasing hormone receptors: the ovine receptor is C-terminally truncated. Endocrinology 142:2660-8
Pombo, C M; Zalvide, J; Gaylinn, B D et al. (2000) Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. Endocrinology 141:2113-9
Nass, R; Gilrain, J; Anderson, S et al. (2000) High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary. Endocrinology 141:2084-9
Gaylinn, B D; Dealmeida, V I; Lyons Jr, C E et al. (1999) The mutant growth hormone-releasing hormone (GHRH) receptor of the little mouse does not bind GHRH. Endocrinology 140:5066-74
Thorner, M O (1999) The discovery of growth hormone-releasing hormone. J Clin Endocrinol Metab 84:4671-6
Lopes, M B; Gaylinn, B D; Thorner, M O et al. (1997) Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors. Am J Pathol 150:1885-91
Zysk, J R; Gaylinn, B D; Lyons, C E et al. (1996) Purification of the growth hormone releasing hormone receptor with a C-terminal, biotinylated affinity ligand. Biochem Biophys Res Commun 221:133-9
Horikawa, R; Hellmann, P; Cella, S G et al. (1996) Growth hormone-releasing factor (GRF) regulates expression of its own receptor. Endocrinology 137:2642-5

Showing the most recent 10 out of 12 publications